These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 334400)

  • 1. Studies on the mechanism of the complement-mediated inhibition of the Fc and C3 receptors of B lymphocytes.
    Erdei A; Füst G; Sármay G; Medgyesi GA; Gergely J
    Clin Immunol Immunopathol; 1977 Nov; 8(3):367-76. PubMed ID: 334400
    [No Abstract]   [Full Text] [Related]  

  • 2. Epstein-Barr virus (EBV) receptors, complement receptors, and EBV infectibility of different lymphocyte fractions of human peripheral blood. I. Complement receptor distribution and complement binding by separated lymphocyte subpopulations.
    Yefenof E; Bakacs T; Einhorn L; Ernberg I; Klein G
    Cell Immunol; 1978 Jan; 35(1):34-42. PubMed ID: 340053
    [No Abstract]   [Full Text] [Related]  

  • 3. Binding of soluble immune complexes to human lymphoblastoid cells. I. Characterization of receptors for IgG Fc and complement and description of the binding mechanism.
    Theofilopoulos AN; Dixon FJ; Bokisch VA
    J Exp Med; 1974 Oct; 140(4):877-94. PubMed ID: 4139225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functionally active C1 on the surface of human peripheral lymphocytes: its role in the complement-mediated inhibition of the Fc receptor of B lymphocytes.
    Füst G; Erdei A; Sármay G; Medgyesi GA; Gergely J
    Clin Immunol Immunopathol; 1976 May; 5(3):377-87. PubMed ID: 776475
    [No Abstract]   [Full Text] [Related]  

  • 5. Surface markers of complement receptor lymphocytes.
    Ross GD; Winchester RJ; Rabellino EM; Hoffman T
    J Clin Invest; 1978 Nov; 62(5):1086-92. PubMed ID: 711854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of Fc receptor mediated functions by split products of C3.
    Gergely J; Erdei A; Fábry Z
    Mol Immunol; 1984 Dec; 21(12):1205-10. PubMed ID: 6240595
    [No Abstract]   [Full Text] [Related]  

  • 7. C3 binds with similar efficiency to Fab and Fc regions of IgG immune aggregates.
    Antón LC; Ruiz S; Barrio E; Marqués G; Sánchez A; Vivanco F
    Eur J Immunol; 1994 Mar; 24(3):599-604. PubMed ID: 8125130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assay of membrane complement receptors (CR1 and CR2) with C3b- and C3d-coated fluorescent microspheres.
    Lambris JD; Ross GD
    J Immunol; 1982 Jan; 128(1):186-9. PubMed ID: 7033372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human monocyte spreading in vitro--inducers and effects on Fc and C3 receptors.
    Douglas SD
    Cell Immunol; 1976 Feb; 21(2):344-9. PubMed ID: 1260865
    [No Abstract]   [Full Text] [Related]  

  • 10. Methods for the identification of human B lymphocytes.
    Shannon EJ; Hastings RC
    J Immunol Methods; 1977; 18(3-4):321-35. PubMed ID: 73562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complement and Fc receptors on cord blood and adult neutrophils.
    Pross SH; Hallock JA; Armstrong R; Fishel CW
    Pediatr Res; 1977 Feb; 11(2):135-7. PubMed ID: 320545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surface characteristics of the human K (killer) lymphocyte.
    Eremin O; Kraft D; Coombs RR; Franks D; Ashby J; Plumb D
    Int Arch Allergy Appl Immunol; 1977; 55(1-6):112-25. PubMed ID: 304041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the macrophage receptro for complement and demonstration of its functional independence from the receptor for the Fc portion of immunoglobulin G.
    Griffin FM; Bianco C; Silverstein SC
    J Exp Med; 1975 Jun; 141(6):1269-77. PubMed ID: 1092796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complement receptors on guinea pig epidermal Langerhans cells.
    Berman B; Gigli I
    J Immunol; 1980 Feb; 124(2):685-90. PubMed ID: 7356709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nephritic factor, C3 splitting activity, C3 and factor B breakdown products in glomerular diseases.
    De Vecchi A; Montagnino G; Scalia P; Tarantino A
    Ric Clin Lab; 1980; 10(1):93-7. PubMed ID: 6781054
    [No Abstract]   [Full Text] [Related]  

  • 16. Interaction of C3 and C3b with immunoglobulin G.
    Kulics J; Rajnavölgyi E; Füst G; Gergely J
    Mol Immunol; 1983 Aug; 20(8):805-10. PubMed ID: 6621540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of human lymphocytes with fluid phase human C3b detected by immunofluorescence.
    Simonian S; Molenaar JL; Zeijlemaker WP; Knape JT; Bakker S; Pondman KW
    Eur J Immunol; 1976 Jan; 6(1):52-6. PubMed ID: 823035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ia antigen expression on human epidermal Langerhans cells.
    Rowden G; Lewis MG; Sullivan AK
    Nature; 1977 Jul; 268(5617):247-8. PubMed ID: 329141
    [No Abstract]   [Full Text] [Related]  

  • 19. Semiquantitative determination of Cc and C3 receptors on human lymphocytes by isotope-labelled marker cells.
    Jonsson V; Christensen BE
    Scand J Haematol; 1977 Oct; 19(4):367-75. PubMed ID: 303371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Native C3 does not bind to the C3b receptor (CR1) of human blood B lymphocytes or alter immunoglobulin synthesis.
    Berger M; Fleisher TA
    J Immunol; 1983 Mar; 130(3):1021-3. PubMed ID: 6600466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.